Valuation: China Biotech Services Holdings Limited

Market Cap 634M 80.87M 70.29M 65.62M 60.24M 114M 7.71B 116M 774M 303M 3.84B 304M 297M 12.68B P/E 2024
-2.49x
P/E 2025 -11.2x
Enterprise Value 1.02B 130M 113M 105M 96.6M 182M 12.36B 185M 1.24B 486M 6.16B 487M 476M 20.33B EV / Sales 2024
9.45x
EV / Sales 2025 15.7x
Free-Float
35.46%
Yield 2024 *
-
Yield 2025 -
1 day+6.92%
1 week+6.92%
Current month+12.10%
1 month+57.95%
3 months-3.47%
6 months-10.90%
Current year-12.03%
1 week 0.59
Extreme 0.59
0.7
1 month 0.42
Extreme 0.425
0.73
Current year 0.3
Extreme 0.3
0.92
1 year 0.3
Extreme 0.3
1.33
3 years 0.25
Extreme 0.25
1.33
5 years 0.25
Extreme 0.25
2.64
10 years 0.16
Extreme 0.156
2.64
Manager TitleAgeSince
Director of Finance/CFO - -
Compliance Officer 55 26/05/2022
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 07/08/2017
Director/Board Member 44 15/09/2017
Chairman 55 28/08/2017
Date Insider Type Main position Quantity % Market Cap.
9/2/24 A Other

Director

3,220,000 0.3300%
6/13/24 A Other

Director

5,000,000 0.5191%
1/19/24 A Other

Chairman

30,000 0.0031%
Change 5-day change 1-year change 3-year change Capi.($)
+6.92%+6.92%+6.92%+6.92% 80.87M
+0.90%-1.59%+68.67%+41.78% 134B
+1.00%+4.36%+13.91%+50.18% 88.03B
+0.56%+1.18%+8.96%+57.59% 29.01B
-0.45%+0.05%+35.76%+69.69% 25.6B
+1.49%+2.76%-8.46%-16.37% 22.18B
-1.88%+2.72%+58.13%+236.23% 20.13B
-2.67%-1.11%+68.75%+130.09% 15B
-1.67%+1.37%+5.12%-1.39% 14.73B
+0.92%+2.23%+3.65%-5.10% 13.68B
Average +0.51%+1.48%+26.14%+56.96% 36.29B
Weighted average by Cap. +0.43%+1.47%+37.95%+54.41%

Financials

2024 2025
Net sales 70.51M 8.99M 7.81M 7.3M 6.7M 12.63M 857M 12.85M 86.02M 33.69M 427M 33.77M 33.02M 1.41B 73.5M 9.37M 8.15M 7.61M 6.98M 13.16M 893M 13.39M 89.67M 35.12M 446M 35.21M 34.43M 1.47B
Net income -198M -25.27M -21.96M -20.5M -18.82M -35.49M -2.41B -36.11M -242M -94.68M -1.2B -94.91M -92.81M -3.96B -68.78M -8.77M -7.62M -7.12M -6.53M -12.32M -836M -12.53M -83.91M -32.86M -417M -32.94M -32.21M -1.38B
Net Debt 169M 21.54M 18.72M 17.48M 16.04M 30.25M 2.05B 30.78M 206M 80.71M 1.02B 80.91M 79.12M 3.38B 383M 48.82M 42.43M 39.61M 36.36M 68.56M 4.65B 69.76M 467M 183M 2.32B 183M 179M 7.65B
Logo China Biotech Services Holdings Limited
China Biotech Services Holdings Ltd, formerly Rui Kang Pharmaceutical Group Investments Ltd, is an investment holding company principally engaged in the provision of medical health check services. The Company operates its business through six segments. The Medical and Health Related Services segment provides medical laboratory testing services and health check services. The Insurance Brokerage segment is engaged in the provision of brokerage services. The Immunotherapy segment provides tumor immune call therapy, immune cell storage and health management services. The Pharmaceutical Products segment is engaged in the manufacture, research and development, sale and distribution of health related and pharmaceutical products. The Securities segment is engaged in the trading of securities. The Others segment is engaged in the money lending business and provision of logistic services.
Employees
142
Date Price Change Volume
04/08/26 HK$0.6950 +6.92% 30,000
03/08/26 HK$0.6500 +4.84% 510,000
31/07/26 HK$0.6200 0.00% 555,000
30/07/26 HK$0.6200 0.00% 450,000
29/07/26 HK$0.6200 -4.62% 235,000
  1. Stock Market
  2. Stocks
  3. 8037 Stock